NickPowellLab

IBD research group at Imperial College London.

[Imperial Department of Immunology & Inflammation @ImperialImmuno]

We're #hiring new non‑clinical Assistant Professors at @ImperialMed!

Want to join us at @ImperialImmuno?

Make sure to choose ‘Immunology and Inflammation’ as your first preference when applying.

✍️Apply by 11 March 2026.
https://t.co/pILoIAT3My

[Seb @ibdseb]

A true legend in the field of IBD - your memory will continue to inspire us

Fitting tribute to Prof. Brian Feagan from #ECCO Family
https://t.co/ogRVEAbW4t

[NickPowellLab @NickPowellLab]

@RPanaccione Beautiful words Remo. Heartfelt love from the UK IBD community to our friends and colleagues in Canada. ❤️

[Seb @ibdseb]

Great progress in recruitment to @ACESO_ASUC this week with 7 patients randomised 📈
2 patients each included by @IbdHull & @imperialcollege teams
1 patient each included by teams from Manchester , Oxford , Leeds
Thank you to participants and 🙏🏼🙏🏼to site teams for all the hard work
We can 👌 do this in 🇬🇧- to make progress in a challenging phenotype of #IBD
#Collaboration

[Metabolism, Digestion & Reproduction @ImperialMDR]

MDR researchers launch a new trial, funded by @GSK, exploring improved vaccine responses in patients with inflammatory bowel disease #IBD (@NickPowellLab @IHepatology)

Find out more ⬇️
https://t.co/VZS3KQtxcs

[Seb @ibdseb]

Congratulations to @imperialcollege team led by Dr James Alexander & @NickPowellLab for randomising their first patient to @ACESO_ASUC study

And they have done that within 2️⃣4️⃣hours of receiving green light !!!
🚦👏👏

Thanks to the participant and the entire team in particular research nurse Isabel
Many more to come 🤞

[Seb @ibdseb]

Our eagerly awaited #RCT on #JAKis #Upadacitinib in Acute Severe Colitis is now recruiting
The ACESO study @ACESO_ASUC

❇️Double blind placebo controlled
❇️ Upfront #upa + IV steroids Vs Iv steroids + Placebo
❇️Option for entry into rescue sub-studies for non responders

📢📣 3️⃣0️⃣ 🇬🇧 sites
Say hello 👋 for updates if at #BSGLIVE25

[NickPowellLab @NickPowellLab]

@KorcsmarosLab @Y_ECCO_IBD Love this meeting!

[St Mark's Hospital @StMarksHospital]

Congratulations to Professor Ailsa Hart, IBD Research Lead at St Mark’s. 🌟

At ECCO 2025, Professor Hart presented the latest results of SC guselkumab for moderate to severe active Crohn’s disease at the prestigious Saturday plenary session. Following this, she was awarded the ECCO Global Grant on behalf of a global team of researchers to advance perianal Crohn’s disease research worldwide — a remarkable achievement driving innovation in IBD care.

A fantastic recognition of her dedication to improving patient outcomes! 🙌🏻

[Shomron Ben-Horin @ShomronH]

Albeit retrospective, an important reassuring data on safety of GLP1s weight reduction in IBD.
I tell my pts that Obesity+associated HTN/diabetes/hyperlipedmia end up killing far more IBD pts than (fortunately very very rare now) death d/t IBD itself.
This is whats at stake !

[Jonathan Lo @DrJonLo]

@LabWaggoner @NickPowellLab @Lukuscyte Thanks for sharing this incredibly long labour of love!

[Waggoner Lab @LabWaggoner]

CTLA-4 expressing ILCs modulate mucosal homeostasis in a microbiota dependent manner @NickPowellLab @DrJonLo @Lukuscyte
https://t.co/1KzeVU4KHM

[NickPowellLab @NickPowellLab]

@KorcsmarosLab @ImperialMDR Was a pleasure to host you Edu, and see the brilliant work you have been doing. 👏👏👏👏

[NickPowellLab @NickPowellLab]

@DocKateLynch Fantastic! Jane is an inspirational leader. Wonderful to see her talk about her brilliant career and be presented with this prestigious award in front of her mother and other family members. 👏 👏 👏

[NickPowellLab @NickPowellLab]

Thank you for these kind words Steven. Wonderful to be here!

🇦🇺 🤝 🇬🇧

[Steven Bollipo @stevenbollipo]

I normally switch off when I see a basic science slide but @NickPowellLab now got me fascinated by IL22! I wish all translational researchers could present concepts so clearly for simple clinical people like me 🤯
@AGWmeeting #AGW2024 #AGW24

[NickPowellLab @NickPowellLab]

Thank you Kate!

And thank you for putting together a wonderful tour of the wineries of the Adelaide Hills! Beautiful country and wonderful wine!
🍇 🍷 😊 👏

[Kate Lynch @DocKateLynch]

Masterful Bushell Lecture by @NickPowellLab on his IBD mucosal immunology research - specifically,
looking at IL-22 and its role in IBD - predicts response to ustekinumab, unregulates neutrophil attracting chemokines, among others. #AGW2024

[NickPowellLab @NickPowellLab]

Excited to attend my first Australian Gastroenterology Week in Adelaide. Thank you to my wonderful Australian colleagues for their generous hospitality @Prof_NickTalley @DocKateLynch Jane Andrews Susan Connor

[NickPowellLab @NickPowellLab]

@guthealthmd @ibdgc @NIDDKgov Brilliant work Mark and team. Shall we do early FMT post op???

[WeersmaLab @WeersmaLab]

Moving towards gut dysbiosis testing in cancer immunotherapy resistance.
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome: Cell https://t.co/dNGYwbkpS0

[Imperial Enterprise @ImperialIdeas]

🏆🌍 @imperialcollege ranked #2 in the world and 1st in the UK and Europe in this 2025 QS @worlduniranking - https://t.co/MBhL918xk3

We're delighted that the ranking reflects how we've consistently improved innovation support and entrepreneurship for real-world impact.💙